story of the week
Efficacy and Safety of Ravulizumab in Patients With Aquaporin-4–Positive NMOSD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Annals of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder
Ann. Neurol 2023 Mar 03;[EPub Ahead of Print], SJ Pittock, M Barnett, JL Bennett, A Berthele, J de Seze, M Levy, I Nakashima, C Oreja-Guevara, J Palace, F Paul, C Pozzilli, M Yountz, K Allen, Y Mashhoon, HJ KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.